Literature DB >> 7567992

De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.

A M Fra1, E Williamson, K Simons, R G Parton.   

Abstract

Caveolae are plasma membrane invaginations, which have been implicated in endothelial transcytosis, endocytosis, potocytosis, and signal transduction. In addition to their well-defined morphology, caveolae are characterized by the presence of an integral membrane protein termed VIP21-caveolin. We have recently observed that lymphocytes have no detectable VIP21-caveolin and lack plasma membrane invaginations resembling caveolae. Here we transiently express VIP21-caveolin in a lymphocyte cell line using the Semliki Forest virus expression system and show de novo formation of plasma membrane invaginations containing VIP21-caveolin. These invaginations appear homogeneous in size and morphologically indistinguishable from caveolae of nonlymphoid cells. Moreover, the glycosylphosphatidylinositol-anchored protein. Thy1, patched by antibodies, redistributes to the newly formed caveolae. Our results show that VIP21-caveolin is a key structural component required for caveolar biogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567992      PMCID: PMC41025          DOI: 10.1073/pnas.92.19.8655

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Caveolin, a protein component of caveolae membrane coats.

Authors:  K G Rothberg; J E Heuser; W C Donzell; Y S Ying; J R Glenney; R G Anderson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Striped structures on the cytoplasmic surface membranes of the endothelial vesicles of the rat aorta revealed by quick-freeze, deep-etching replicas.

Authors:  T Izumi; Y Shibata; T Yamamoto
Journal:  Anat Rec       Date:  1988-03

3.  Differential target cell susceptibility to SFV-immune cytotoxic T-cells.

Authors:  A Müllbacher; N J King
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  A new generation of animal cell expression vectors based on the Semliki Forest virus replicon.

Authors:  P Liljeström; H Garoff
Journal:  Biotechnology (N Y)       Date:  1991-12

Review 5.  Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact?

Authors:  N J Severs
Journal:  J Cell Sci       Date:  1988-07       Impact factor: 5.285

6.  Caveolae and sorting in the trans-Golgi network of epithelial cells.

Authors:  P Dupree; R G Parton; G Raposo; T V Kurzchalia; K Simons
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

7.  Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure.

Authors:  K R Peters; W W Carley; G E Palade
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

8.  Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton.

Authors:  J R Glenney; L Zokas
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

9.  Major histocompatibility complex-restricted recognition of retroviral superantigens by V beta 17+ T cells.

Authors:  M A Blackman; F E Lund; S Surman; R B Corley; D L Woodland
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles.

Authors:  T V Kurzchalia; P Dupree; R G Parton; R Kellner; H Virta; M Lehnert; K Simons
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

View more
  174 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

3.  Oxidative stress inhibits caveolin-1 palmitoylation and trafficking in endothelial cells.

Authors:  Marie-Odile Parat; Rafal Z Stachowicz; Paul L Fox
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  Expression of caveolin by bovine lymphocytes and antigen-presenting cells.

Authors:  James Harris; Dirk Werling; Michael Koss; Paul Monaghan; Geraldine Taylor; Chris J Howard
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

5.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Clustering induces a lateral redistribution of alpha 2 beta 1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization.

Authors:  Paula Upla; Varpu Marjomäki; Pasi Kankaanpää; Johanna Ivaska; Timo Hyypiä; F Gisou Van Der Goot; Jyrki Heino
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

7.  Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions.

Authors:  Marie-Odile Parat; Bela Anand-Apte; Paul L Fox
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

Review 8.  Cellular endocytosis and gene delivery.

Authors:  Jennifer E Ziello; Yan Huang; Ion S Jovin
Journal:  Mol Med       Date:  2010-02-03       Impact factor: 6.354

9.  Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes.

Authors:  Hans Thorn; Karin G Stenkula; Margareta Karlsson; Unn Ortegren; Fredrik H Nystrom; Johanna Gustavsson; Peter Stralfors
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

10.  Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells.

Authors:  K R Solomon; M A Mallory; R W Finberg
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.